Company intelligence / Profile preview

Center for Inherited Blood Disorders

Orange, California, United States

Ownership: Private
Employees: ~32
Development stage: Other

Overview

CIBD provides comprehensive, multidisciplinary outpatient and pharmacy care for individuals with rare inherited blood disorders, focusing on improved quality of life and disease management rather than drug development or therapeutic product pipelines. Clinical outcomes focus on improving access to care and management of bleeding disorders in California.[3][5]

Therapeutic areas: Hematology
Modalities: Non-pharmacological therapyBiologicSmall molecule
Industry: Non-Academic Healthcare

Partnerships

Affiliations with local hospitalsCollaborations with University of California, IrvineWestern States Hemophilia NetworkCommunity provider networks

Beyond the preview

Go deeper on Center for Inherited Blood Disorders.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Center for Inherited Blood Disorders.

Explore the full profile